Upadacitinib as salvage therapy in adolescents with acute severe ulcerative colitis refractory to conventional treatments
UPA is a promising short-term salvage therapy in adolescent ASUC cases resistant to conventional treatments. Prospective studies are warranted to elucidate its long-term efficacy and safety in this specific population. These findings provide a novel therapeutic avenue for managing ASUC in adolescents, offering hope for those encountering treatment challenges.
Authors
- Andrew Dickerson (ORCID: https://orcid.org/0000-0002-3059-0908)
- Laura E. Bauman (ORCID: https://orcid.org/0000-0002-9753-5946)
- Jeannie S. Huang (ORCID: https://orcid.org/0000-0002-2742-5557)
Institutions
- University of California San Diego (US)
- Rady Children's Hospital-San Diego (US)
Publication Details
- Journal
- JPGN Reports
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1002/jpr3.12124
- Citations
- 10
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 5.50
Funders
- Crohn's and Colitis Foundation
- National Institute on Minority Health and Health Disparities